Drug Utilization Review | AMCP. org Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met
Drug Utilization Review (DUR) | Medicaid Medicaid DUR is a structured, ongoing program that interprets patterns of drug use in Medicaid programs and includes prospective drug review, retrospective drug use review, data assessment of drug use against predetermined standards, and ongoing educational outreach activities conducted by Medicaid state agencies, managed health care systems
MassHealth Drug Utilization Review (DUR) | Mass. gov MassHealth Drug Utilization Review (DUR) The main goal of the DUR Program is to ensure that prescribed drugs are appropriate, medically necessary, and not likely to result in medication-related problems What would you like to do? What you need to know
What does DUR mean to you? Definitions and purposes abound - Relias Media The phrase drug utilization review, or DUR, takes several different shapes and meanings, depending on the situation and whom you’re talking to Its purpose varies too, often swaying with current issues and problems in pharmacy DUR first appeared with the Omnibus Budget Reconciliation Act of 1990 (OBRA ’90)
What are Drug Utilization Reviews (DUR) - Pequot Healthcare Drug Utilization Reviews (DUR), also referred to as Drug Utilization Evaluations (DUE) or Medication Utilization Evaluations (MUE), are defined as an authorized, structured, ongoing review of healthcare provider prescribing, pharmacist dispensing, and patient use of medication
Drug Utilization Review - Academy of Managed Care Pharmacy Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met
State Drug Utilization Review Reporting | Medicaid The Centers for Medicare Medicaid Services (CMS) requires states to provide annual drug utilization review (DUR) reports on their: Nature and scope of the prospective and retrospective drug use review programs; Summary of DUR interventions; Cost savings generated from their DUR programs; Program’s operations; Adoption of innovative DUR